Examination of Witnesses (Questions 583
- 584)
WEDNESDAY 21 JUNE 2000
MRS ANDEE
MCKEOWN
AND MR
GLYN ROBERTS
Chairman
583. I call Mrs Andee McKeown from the Ulster
Cancer Foundation. You are going to speak first, Mr Roberts, are
you?
(Mr Roberts) By way of an introduction
to Mrs McKeown. Mrs McKeown is a member of the Ulster Cancer Foundation
patients' forum, very confident and indeed like many cancer patients
the world over a very brave person facing up to the problem of
cancer in her life. What she will be doing is very much looking
at the issue of cancer research from her own particular personal
experiences. She will probably outline what many cancer patients
in this room will clearly identify with. I should like to hand
you over now to Mrs McKeown.
(Mrs McKeown) I am appearing before you today as a
cancer patient and as a member of the Ulster Cancer Foundation's
patients' forum. I was diagnosed with breast cancer in December
1993 and I have had two mastectomies and subsequent breast reconstruction.
Unlike many of the others appearing before this Committee I am
not an expert in oncology, epidemiology or any other cancer related
medical disciplines. I am here primarily to represent the patients'
point of view. I cannot therefore impress you with professional
knowledge. However, what I want to do is impress upon you the
absolute critical need not only for high quality preventive treatment
and palliative cancer care services, but also for adequately funded
well coordinated cancer research directed at ending the scourge
of cancer at the earliest possible time. The word research has
an academic ring to it. Part of my purpose in attending here today
is to move the focus from the abstract to the personal, to put
a human face on cancer. One in three people in this room will
probably be given a cancer diagnosis at some stage in their life
and one in four of you will die from that disease. Our cancer
survival rates in Northern Ireland are amongst the lowest in Europe.
They are on a par with countries such as Poland and Latvia. However,
if you live in a modern European state such as Switzerland or
France, you have a much better chance of a five-year survival
post-cancer diagnosis. Moreover, in the United States, the survival
rate for breast cancer is 30 per cent higher than it is in Northern
Ireland. These are appalling statistics, but that is the reality
in Northern Ireland. This in essence means that people are needlessly
dying prematurely and they are suffering grievously because of
the failure to invest adequately in cancer services including
research in Northern Ireland. This is not an abstract problem.
For me it is up close and personal and of course it could be the
same for any of you in this room. My appearance today on behalf
of the Ulster Cancer Foundation and the patients' forum is to
bring to your attention and in turn the wider public the disturbing
facts regarding underinvestment in this issue of cancer care and
research, an issue which touches every family in the land. The
crux of the matter here is one about relative priorities in terms
of expenditure within the Government's overall spending programme.
Cancer care and research are a priority but it does not appear
to be reflected in the hierarchy of government spending priorities.
In 1997 in the UK the amount of money spent on anti-cancer chemotherapy
drugs in the UK per head was 95p. In America it was £7.76
per capita. In Germany it was £6.24. It is no wonder that
our survival rates are so low. The Calman report has given us
a blueprint for cancer services for the future in Northern Ireland.
However, without the funding at an adequate level commensurate
with need, how can the cancer centre of excellence ever work well.
Moreover if we cannot adequately fund cancer treatment how can
we ever fund the pursuit of a cure? I was recently given to understand
that the investment by voluntary organisations in the UK in cancer
research is significantly greater than that of government. That
emphatically underscores the point made about the seriousness
or otherwise with which government takes this issue. Mr Wood in
his submission will speak of the excellent cancer research infrastructure
in Northern Ireland, but he has stressed the necessity for government
to provide the necessary resources to match the voluntary sector
in its commitment to provide quality care. As a member of the
patients' forum, I wholeheartedly endorse this. Cancer is a complex
issue but it is not invincible and it can be defeated. To achieve
this would take an utter and complete determination by all involved
in the disease on an international or global basis. Cancer has
no respect for frontiers. I recall the determination of the late
President Kennedy to put a man on the moon within ten years like
a pipe dream. That desire was fulfilled within the decade. Other
extreme situations such as warfare have often been the catalyst
for unforeseen breakthroughs in science and in technology. There
is an undeclared war being waged against cancer and it has marshalled
together people and groups like the voluntaries, politicians,
doctors and researchers to try to find a cure. Maybe with the
proper funding that day when cancer is no longer a threat could
be sooner rather than later. Removing the threat of cancer must
be pursued with a sense of conviction. The only question must
be when, not whether. The question of when is dependent on an
absolute determination to find a cure and the translation of that
determination into willingness of governments to fund to the required
level of resources and to give it the priority it so evidently
needs.
584. Thank you very much indeed. We do not have
time for questions but may I just say that we welcome your evidence
and that yesterday three of the Committee went to Ulster and they
looked at cancer treatment there, so we are including Ulster,
as we jolly well should, in our inquiry and thank you for coming
today so soon after our visit yesterday.
(Mrs McKeown) Thank you for your time.
|